Search - tctmd.com

Displaying 21 - 40 of 359

Sort: Relevancy | Date

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

Presentation TCT 2024

Atrial FMR From a Surgeon’s Perspective: At the Crossroads of Surgical and Transcatheter Intervention

Presenter: Robert Smith

October 29, 2024

Presentation TCT 2024

Atrial FMR From a Structuralist’s Perspective: M-TEER and Beyond

Presenter: Stephan Baldus

October 29, 2024

Presentation TCT 2024

Atrial FMR Primer: Epidemiology, Pathophysiology, Imaging Features, and Clinical Presentation

Presenter: Federico Asch

October 29, 2024

Presentation TCT 2024

Medical and Atrial Fibrillation Management for Atrial FMR

Presenter: Gabriel Sayer

October 29, 2024

Presentation TCT 2024

Patient Selection For MR Intervention: Which Patients To Treat and When?

Presenter: Lucy Safi

October 29, 2024

Presentation TCT 2024

TCT 947: AltaValve Atrial Fixation System for Treatment of Severe Atrial Functional Mitral Regurgitation

Presenter: John Saxon

October 29, 2024

Presentation TCT 2024

TCT 1432: Rescue TEER for Cardiogenic Shock in Atrial Functional Mitral Regurgitation

Presenter: Sina Salehi Omran

October 28, 2024

Presentation TCT 2024

TCT 625: A Lower Ratio of Regurgitant Volume to Left Atrium Volume Is Associated With a Higher Incidence of Heart Failure Hospitalization in Patients With Ventricular Functional Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair

Presenter: Masafumi Yoshikawa

October 28, 2024

Presentation TCT 2024

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

Presenter: Ralph von Bardeleben

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Opinion Editor's Corner

What’s Going to Be Hot at ESC 2024

Shelley Wood

August 23, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

News Conference News NY Valves 2024

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Todd Neale

June 11, 2024

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

Advertisement

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Atrial FMR From a Surgeon’s Perspective: At the Crossroads of Surgical and Transcatheter Intervention

Atrial FMR From a Structuralist’s Perspective: M-TEER and Beyond

Atrial FMR Primer: Epidemiology, Pathophysiology, Imaging Features, and Clinical Presentation

Medical and Atrial Fibrillation Management for Atrial FMR

Patient Selection For MR Intervention: Which Patients To Treat and When?

TCT 947: AltaValve Atrial Fixation System for Treatment of Severe Atrial Functional Mitral Regurgitation

TCT 1432: Rescue TEER for Cardiogenic Shock in Atrial Functional Mitral Regurgitation

TCT 625: A Lower Ratio of Regurgitant Volume to Left Atrium Volume Is Associated With a Higher Incidence of Heart Failure Hospitalization in Patients With Ventricular Functional Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

What’s Going to Be Big at TCT 2024?

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

What’s Going to Be Hot at ESC 2024

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content